Stefano Cafarotti

[JTO & JTO CRR @JTOonline]

Most Popular: Highly Sensitive Detection of EGFR T790M Mutation in Pre-TKI Specimens of EGFR-Mutated NSCLC: I... http://t.co/99uYRmIBqK

[Targeted Oncology @TargetedOnc]

Ceritinib Approved by FDA for ALK-Positive NSCLC http://t.co/BQZmyG8gUd

[Medscape Oncology @MedscapeOnc]

Ceritinib (Zykadia) - new drug for patients with ALK+ve NSCLC who progress on crizotinib (Xalkori) http://t.co/WQKvKDP5MZ

[Oncology Tube @oncologytube]

Debate: Adjuvant therapy for resected node negative stage I NSCLC? - Sometimes http://t.co/tvIFbkh8jg

[JTO & JTO CRR @JTOonline]

Most Popular: A Pooled Analysis of Limited-Stage Small-Cell Lung Cancer Patients Treated with Induction Chemot... http://t.co/axpq4EdDGt

[ESTS @thoracic]

Welcome to our new followers, as @thoracic breaks the 200 followers barrier.

[JTO & JTO CRR @JTOonline]

Current ToC: Patterns of Failure after Stereotactic Body Radiation Therapy or Lobar Resection for Clinical Sta... http://t.co/BwhD6Or2f4

[JTO & JTO CRR @JTOonline]

Ahead-of-Print: Radiotherapy for Intubated Patients with Malignant Airway Obstruction: Futile or Facilitating ... http://t.co/gimTdH5m03

[American Thoracic Society (ATS) @atscommunity]

Combination maintenance therapy with erlotinib & bevacizumab offers little benefit for NSCLC patients: http://t.co/0oe6E3bxuL

[JTO & JTO CRR @JTOonline]

Current ToC: Acute Autoimmune Hepatitis, Myositis, and Myasthenic Crisis in a Patient with Thymoma: No abstrac... http://t.co/BXIsLuucKF

[JTO & JTO CRR @JTOonline]

Ahead-of-Print: Screening High-Risk Populations for Lung Cancer: Guideline Recommendations: Introduction: The ... http://t.co/8FmIUqbX52

[Stefano Cafarotti @SCafarotti]

http://t.co/fMgjCFdx76

[Stefano Cafarotti @SCafarotti]

http://t.co/dopI91BRQ8

[Stefano Cafarotti @SCafarotti]

http://t.co/mgfhDDUoKd

[JTO & JTO CRR @JTOonline]

Current ToC: Challenges to Implementation of an Epidermal Growth Factor Receptor Testing Strategy for Non-Smal... http://t.co/QdMqhd5dMm

[Stefano Cafarotti @SCafarotti]

http://t.co/xy1Wf4GG1P

[JTO & JTO CRR @JTOonline]

Current ToC: Lymph Node Ratio May Predict the Benefit of Postoperative Radiotherapy in Non–Small-Cell Lung Can... http://t.co/gz991DYtrl

[JTO & JTO CRR @JTOonline]

Current ToC: Specificities of Lung Adenocarcinoma in Women Who Have Never Smoked: Introduction: No clear data ... http://t.co/2yCr6Uw6RD

[JTO & JTO CRR @JTOonline]

Current ToC: Detection of ALK Rearrangement by Immunohistochemistry in Lung Adenocarcinoma and the Identificat... http://t.co/rgC0MMBLyG

[ESTS @thoracic]

Just back from Birmingham? Our next annual conference 15th-18th June 2014 Copenhagen